Mid
N
NRIXAI Stock Diagnostic Report
Baird reiterates Nurix stock Outperform rating at $33 target
Baird has maintained an 'Outperform' rating and a target price of $33 for Nurix, presenting a positive outlook.
View Source Article ↗
AI CATALYST SCORE65 / 100Score computed by Sentinel V12
REFERENCE PRICENot measuredReference entry price at analysis time
+ANALYSIS HISTORY
NRIX Analysis History (Last 30 Days)